Mum runs Bradford 10k in memory of toddler who died from epilepsy
A mother whose daughter died from a rare epilepsy syndrome is running Bradford 10k in her memory, 10 years after her death.Cheryl Murphy, from Pudsey, will be joined by nine of her friends and family to run the race on Sunday, after completing the Manchester Marathon in April.Two-year-old Edie died in October 2015 after a seizure caused by hemiplegia Hemiconvulsion syndrome."It's so, so rare," says Ms Murphy. "When the doctor first spoke to us about it, they said that usually, unfortunately, when they have this seizure, because it can't be controlled, the child will likely pass away."So it's one of those things you don't know your child has until they have this seizure. Unfortunately, I don't think there's any testing or any other way to detect it."I only know one other family whose child has hemiplegia Hemiconvulsion syndrome, and we found that after Edie died and the family reached out to me from Australia."
Edie's illness became apparent in April 2015 when she began experiencing febrile convulsions."Edie had a fever then a febrile convulsion in the April, as she had croup, and she had a really high temperature. In the October, she was a bit poorly again with a bit of a cold."The family were moving from Edinburgh to Yorkshire that weekend, and were preparing for the long drive when Edie had another seizure. "My husband went up to check on her and I just knew from the way that he shouted my name that something was wrong."I just knew. I don't know why, because it could have been multiple things. But how he sounded was how I had shouted him when she had the seizure the first time."The only way doctors were able to stop Edie's seizure was by inducing a coma. After five days Ms Murphy and her husband, Tom, were told she had hemiplegia Hemiconvulsion syndrome."They were never able to bring her out of the seizure," says Ms Murphy. "They tried to reduce the sedation but her body was just too damaged."
Weeks later, Ms Murphy began fundraising for Edinburgh Children's Hospital charity and 10 years later the family has raised more than £35,000 for charities including Millie Wright Children's Charity and Epilepsy Action."When we had her funeral, we were sat with all our friends and they started saying, 'I'll do something' and we kind of grew this list," she says."So 2016 became the year of running because we did all the 10ks, but I kept adding things like half marathons and then we did the Yorkshire Marathon."It gave us a way to parent her, even though she wasn't here."We just needed something to focus on other than the fact she died and I liked it in a way because it gave people something to talk to us about."Running was also a way for Ms Murphy to help process her grief - and get some time to herself, as she was also raising her two other daughters, Annie and Eilidh."We used to go out for a run and put music on and it was half an hour to get away from everything and sometimes I'd be crying because a song would come on and I'd be thinking it's Edie's favourite song. "But then the next song would come on and I'd remember her dancing around the kitchen or getting the words slightly wrong."Now, when anybody thinks about us running, they think of Edie. So it was a positive something for her."The family is now raising awareness about hemiplegia Hemiconvulsion syndrome, as it was something they knew nothing about before Edie's diagnosis."I very naively thought there's a few types of epilepsy. We've spent a lot of time raising awareness of the hospital and they deserve every bit of it because they were amazing, but now I'd quite like to focus more on why she passed away," she says.
Ms Murphy first did Bradford 10k in 2019, and has run every race since.The event is organised by the charity Epilepsy Action, which is celebrating its 75th anniversary in 2025. This year will also be special for Ms Murphy because she will be part of a group of 10 – all in specially printed T-shirts."These are all friends that I've made from Pudsey and so they've never met Edie," says Ms Murphy. "They've only known her through what we've shared."It means a lot to me that they want to get involved, but it's also a massive challenge for some of them because it's their first proper race and this is the whole reason they've started running."
Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
13 minutes ago
- The Independent
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
Daily Mail
35 minutes ago
- Daily Mail
Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons
A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.
Daily Mail
35 minutes ago
- Daily Mail
The secrets of Nottinghamshire's remarkable rise: How an injection of youth, clever recruitment and the evolution of Haseeb Hameed has helped charge to County Championship summit
Halfway up the hill, Nottinghamshire are looking down on the rest of the County Championship. As first-class action returns to domestic cricket this weekend, even their most fervent fans would be forgiven for thinking the Division One table has been turned upside down.
